Publications View
Lipid mediator networks in cell signaling: update and impact of cytokines.
Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
Lipoxins: putative braking signals in host defense, inflammation and hypersensitivity.
Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.
Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.
Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells.
Authors: Authors: Datta YH, Romano M, Jacobson BC, Golan DE, Serhan CN, Ewenstein BM.
Circulation
View full abstract on Pubmed
Circulation
View full abstract on Pubmed
Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.
Authors: Authors: Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL.
Biochemistry
View full abstract on Pubmed
Biochemistry
View full abstract on Pubmed
Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions.
Lipoxin biosynthesis and actions: role of the human platelet LX-synthase.
Transcellular biosynthesis of lipoxin A4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis.
Authors: Authors: Papayianni A, Serhan CN, Phillips ML, Rennke HG, Brady HR.
Kidney Int
View full abstract on Pubmed
Kidney Int
View full abstract on Pubmed